Use App
Trending
News
Earnings
All
DIA
0.48%
SPY
0.10%
QQQ
1.12%
Trending
SHIB
26.09%
ONDO
2.01%
MLTX
1.76%
PEPE
6.05%
WIF
8.31%
DJT
3.71%
IONQ
3.61%
QNT
7.39%
SMR
8.17%
ELF
1.59%
SHIB
26.09%
ONDO
2.01%
MLTX
1.76%
PEPE
6.05%
WIF
8.31%
DJT
3.71%
IONQ
3.61%
QNT
7.39%
SMR
8.17%
ELF
1.59%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
NBIX
Exchange:
NASDAQ
·
Updated 07:46 PM EDT
NBIX
Neurocrine Biosciences, Inc.
$175.77
$1.62
(0.93%)
Today
·
Closed $175.77
$0.77
(0.44%)
After Hours
3
,
3
3
8
3
,
3
3
8
Earnings
Jul 30
Mkt Cap
$17.67B
Vol
1.13M
Full Chart
Fundamentals
Mkt Cap
$17.67B
Volume
-
52W High
$181.18
52W Low
$122.14
PE Ratio
27.02
Avg. Volume
1.23M
EPS (Annual)
$4.67
P/B
5.19
Rev/Employee
$1,430,250.00
Earnings
Jul 30
Advertisement
|
Remove ads.
Latest NBIX News
View
Neurocrine Biosciences Announces Key Leadership Hiring, Promotions
PR Newswire
Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down
Zacks
GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC
Zacks
Loading...
Top Discussions
HIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
6
1.1K votes
SPY
What do you think the S&P 500's ($SPY) return will be next week?
41
95
12.4K votes
HIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile